Clinical and Experimental Nephrology

Papers
(The median citation count of Clinical and Experimental Nephrology is 1. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-10-01 to 2024-10-01.)
ArticleCitations
Hypokalemia in Patients with COVID-1979
The emerging role of magnesium in CKD35
Estimating the prevalence of definitive chronic kidney disease in the Japanese general population30
Incidence and risk factors of acute kidney injury, and its effect on mortality among Japanese patients receiving immune check point inhibitors: a single-center observational study27
A digest of the Evidence-Based Clinical Practice Guideline for Nephrotic Syndrome 202024
Kidney biopsy guidebook 2020 in Japan24
Incidence, risk factors and outcome of acute kidney injury (AKI) in patients with COVID-1924
Anti-pruritic effect of nemolizumab in hemodialysis patients with uremic pruritus: a phase II, randomized, double-blind, placebo-controlled clinical study24
Emerging cross-talks between chronic kidney disease–mineral and bone disorder (CKD–MBD) and malnutrition–inflammation complex syndrome (MICS) in patients receiving dialysis24
Validation of the diagnostic criteria for IgG4-related kidney disease (IgG4-RKD) 2011, and proposal of a new 2020 version23
Relationships between cystatin C- and creatinine-based eGFR in Japanese rural community- dwelling older adults with sarcopenia23
Pathology and pathogenic pathways in fabry nephropathy23
Efficacy and safety of esaxerenone (CS-3150) in Japanese patients with type 2 diabetes and macroalbuminuria: a multicenter, single-arm, open-label phase III study23
Gross hematuria after SARS-CoV-2 vaccination: questionnaire survey in Japan19
Renoprotective effect of GLP-1 receptor agonist, liraglutide, in early-phase diabetic kidney disease in spontaneously diabetic Torii fatty rats19
Intra-body dynamics of d-serine reflects the origin of kidney diseases18
Mesangial C3 deposition and serum C3 levels predict renal outcome in IgA nephropathy18
The roles of histone deacetylases in kidney development and disease18
Preservation of kidney function irrelevant of total kidney volume growth rate with tolvaptan treatment in patients with autosomal dominant polycystic kidney disease18
COVID-19-induced acute renal tubular injury associated with elevation of serum inflammatory cytokine17
Causes of death in patients undergoing maintenance hemodialysis in Japan: 10-year outcomes of the Q-Cohort Study17
Association between serum potassium levels and adverse outcomes in chronic kidney disease: the Fukushima CKD cohort study16
Clinical profile and outcomes of COVID-19 patients with acute kidney injury: a tertiary centre experience from South India15
A digest from evidence-based Clinical Practice Guideline for Polycystic Kidney Disease 202015
Association of serum lncRNA H19 expression with inflammatory and oxidative stress markers and routine biochemical parameters in chronic kidney disease14
iPSC technology-based regenerative medicine for kidney diseases14
Association of neutrophil-to-lymphocyte ratio and risk of cardiovascular or all-cause mortality in chronic kidney disease: a meta-analysis14
Reno-protective effects of Phosphodiesterase 5 inhibitors13
Impact of visceral fat area in patients with chronic kidney disease13
Factors associated with SARS-CoV-2 antibody titers and prognosis of breakthrough infection in hemodialysis patients13
Activators of SIRT1 in the kidney and protective effects of SIRT1 during acute kidney injury (AKI) (effect of SIRT1 activators on acute kidney injury)13
Development and validation of a predictive model for acute kidney injury in patients with moderately severe and severe acute pancreatitis12
Association between serum uric acid and new onset and progression of chronic kidney disease in a Japanese general population: Iki epidemiological study of atherosclerosis and chronic kidney disease12
A digest from evidence-based clinical practice guideline for IgA nephropathy 202012
Clinical efficacy and safety of combination therapy of tocilizumab and steroid pulse therapy for critical COVID-19 in HD patients12
Adult-onset minimal change disease: the significance of histological chronic changes for clinical presentation and outcome12
Activation of AQP2 water channels by protein kinase A: therapeutic strategies for congenital nephrogenic diabetes insipidus12
Nutritional status and risk of contrast-associated acute kidney injury in elderly patients undergoing percutaneous coronary intervention11
The association between frailty and chronic kidney disease; cross-sectional analysis of the Nambu Cohort Study11
A phase 3 multicenter open-label maintenance study to investigate the long-term safety of sodium zirconium cyclosilicate in Japanese subjects with hyperkalemia11
The association between renal elasticity evaluated by Real-time tissue elastography and renal fibrosis11
Comparison of annual eGFR decline among primary kidney diseases in patients with CKD G3b-5: results from a REACH-J CKD cohort study11
Fact-finding survey on health literacy among Japanese predialysis chronic kidney disease patients: a multi-institutional cross-sectional study10
Analysis of risk factors for donation after circulatory death kidney transplantation in Japan10
Evaluation of a newly proposed renal risk score for Japanese patients with ANCA-associated glomerulonephritis10
Low-GDP, pH-neutral solutions preserve peritoneal endothelial glycocalyx during long-term peritoneal dialysis10
Effect of dapagliflozin on the initial estimated glomerular filtration rate dip in chronic kidney disease patients without diabetes mellitus9
Relationship between serum lipid concentrations and impaired renal function in patients with chronic kidney disease: the Fukuoka Kidney Disease Registry Study9
Calcium channel blocker in patients with chronic kidney disease9
MiR-142-3p ameliorates high glucose-induced renal tubular epithelial cell injury by targeting BOD19
Total iron binding capacity is a predictor for muscle loss in maintenance hemodialysis patients9
Immune response to SARS-CoV-2 vaccination among renal replacement therapy patients with CKD: a single-center study9
Creatinine generation rate can detect sarcopenia in patients with hemodialysis9
Safety and efficacy of Tolvaptan in real-world patients with autosomal dominant polycystic kidney disease- interim results of SLOW-PKD surveillance9
Renal prognoses by different target hemoglobin levels achieved by epoetin beta pegol dosing to chronic kidney disease patients with hyporesponsive anemia to erythropoiesis-stimulating agent: a multice9
Zinc deficiency: its prevalence and relationship to renal function in Japan9
Disease severity and renal outcomes of patients with chronic kidney disease infected with COVID-199
Deletion of Alox15 improves kidney dysfunction and inhibits fibrosis by increased PGD2 in the kidney9
A cross-sectional study in patients with IgA nephropathy of correlations between clinical data and pathological findings at the time of renal biopsy: a Japanese prospective cohort study8
Factors predicting decline in renal function and kidney volume growth in autosomal dominant polycystic kidney disease: a prospective cohort study (Japanese Polycystic Kidney Disease registry: J-PKD)8
Effect of lanthanum carbonate and calcium carbonate on the progression of coronary artery calcification among hemodialysis patients with vascular calcification risk: a randomized controlled trial8
Inpatient educational program delays the need for dialysis in patients with chronic kidney disease stage G58
Circ_0000064 knockdown attenuates high glucose-induced proliferation, inflammation and extracellular matrix deposition of mesangial cells through miR-424-5p-mediated WNT2B inhibition in cell models of8
Use of biologic agents and methotrexate improves renal manifestation and outcome in patients with rheumatoid arthritis: a retrospective analysis8
X-chromosome inactivation patterns in females with Fabry disease examined by both ultra-deep RNA sequencing and methylation-dependent assay8
Clinical and morphologic spectrum of renal involvement in idiopathic hypereosinophilic syndrome8
Incidence of end-stage renal disease and risk factors for progression of renal dysfunction in Japanese patients with type 2 diabetes: the Fukuoka Diabetes Registry8
Clinical characteristics of COVID-19 infection in a dialysis center during a nosocomial outbreak8
The association between cognitive impairment/dementia and albuminuria: a systematic review and meta-analysis7
Effectiveness and current status of multidisciplinary care for patients with chronic kidney disease in Japan: a nationwide multicenter cohort study7
Preoperative CT volumetry of estimated residual kidney for prediction of postoperative chronic kidney disease in patients with renal cell carcinoma7
Comparative study of a novel selective urate reabsorption inhibitor “dotinurad” among patient groups with different stages of renal dysfunction7
Impact of water consumption on renal function in the general population: a cross-sectional analysis of KNHANES data (2008–2017)7
Pregnancy outcomes in patients with systemic lupus erythematosus with or without a history of lupus nephritis7
Cardio-ankle vascular index with renal progression and mortality in high atherosclerosis risk: a prospective cohort study in CORE-Thailand7
Effect of tolvaptan in Japanese patients with autosomal dominant polycystic kidney disease: a post hoc analysis of TEMPO 3:4 and TEMPO Extension Japan7
Dialysis-related carpal tunnel syndrome in the past 40 years7
Seasonal variation of serum 25-hydroxyvitamin D level in hemodialysis patients in the northernmost island of Japan7
Clinical and experimental approaches for imaging of acute kidney injury7
Hemodialysis patients with coronavirus disease 2019: reduced antibody response7
SARS-CoV-2 spike protein antibody titers 6 months after SARS-CoV-2 mRNA vaccination among patients undergoing hemodialysis in Japan7
Association of the nutritional risk index for Japanese hemodialysis patients with long-term mortality: The Q-Cohort Study7
New-onset and relapse of nephrotic syndrome following COVID-19 vaccination: a questionnaire survey in Japan7
eGFR slope as a surrogate endpoint for clinical study in early stage of chronic kidney disease: from The Japan Chronic Kidney Disease Database6
Screening of renal anomalies in first-degree relatives of children diagnosed with non-syndromic congenital anomalies of kidney and urinary tract6
Cost-effectiveness of mass screening for dipstick hematuria in Japan6
Tubulointerstitial nephritis: a biopsy case series of 139 Japanese patients6
Impact of polypharmacy on all-cause mortality and hospitalization in incident hemodialysis patients: a cohort study6
KCNQ1OT1 inhibition alleviates high glucose-induced podocyte injury by adsorbing miR-23b-3p and regulating Sema3A6
Efficacy of tolvaptan on advanced chronic kidney disease with heart failure: a randomized controlled trial6
The distribution of eGFR by age in a community-based healthy population: the Japan specific health checkups study (J-SHC study)6
Non-invasive fibrosis assessments of non-alcoholic fatty liver disease associated with low estimated glomerular filtration rate among CKD patients: the Fukuoka Kidney disease Registry Study6
A possible case of carbamazepine-induced renal phospholipidosis mimicking Fabry disease6
Roles of PTH and FGF23 in kidney failure: a focus on nonclassical effects6
Efficacy of continuous erythropoietin receptor activator for end-stage renal disease patients with renal anemia before and after peritoneal dialysis initiation6
Association of magnesium abnormalities at intensive care unit admission with kidney outcomes and mortality: a prospective cohort study6
Altered arginine vasopressin-cyclic AMP-aquaporin 2 pathway in patients with chronic kidney disease6
Chronic kidney disease and clinical outcomes in patients with COVID-19 in Japan6
Performance of ChatGPT and Bard in self-assessment questions for nephrology board renewal6
Initial decline in eGFR to predict tolvaptan response in autosomal-dominant polycystic kidney disease6
PPAR-δ activation reduces cisplatin-induced apoptosis via inhibiting p53/Bax/caspase-3 pathway without modulating autophagy in murine renal proximal tubular cells6
Hypoxia-inducible factor prolyl hydroxylase inhibitors for anaemia in maintenance dialysis: a meta-analysis6
Efficacy and safety of mycophenolate mofetil in the treatment for IgA nephropathy: a meta-analysis of randomized controlled trials6
Renal morphology and function from childhood to adulthood in Turner syndrome6
All-case Japanese post-marketing surveillance of the real-world safety and efficacy of rituximab treatment in patients with refractory nephrotic syndrome6
Expression and prognostic value of CXCL12/CXCR4/CXCR7 axis in clear cell renal cell carcinoma6
Long-term outcomes of IgA nephropathy patients with less than 25% crescents and mild proteinuria6
Improving hepatitis B vaccination rates for advanced chronic kidney disease patients: a quality improvement initiative6
VEGF-VEGFR2 inhibitor-associated hyaline occlusive glomerular microangiopathy: a Japanese single-center experience5
Nationwide survey of the coronavirus disease 2019 prevention and treatment systems for kidney disease patients: a study of Japanese Society of Nephrology-certified educational facilities5
Hematological parameters of anemia and prognosis of non-dialysis-dependent chronic kidney disease: the Fukushima CKD cohort study5
Long-term continuous use of proton-pump inhibitors is associated with renal function decline in patients without acute kidney injury5
Estimating the causal effect of transient anemia status on renal and cardiovascular outcomes in community-dwelling patients in Japan at the beginning of impaired renal function using marginal structur5
A nationwide analysis of renal and patient outcomes for adults with lupus nephritis in Japan5
Blunted humoral immune response to the fourth dose of BNT162b2 COVID-19 vaccine in patients undergoing hemodialysis5
Relationships of hyperchloremia with hypertension and proteinuria in patients with chronic kidney disease5
Brain-derived neurotrophic factor (BDNF): a multifaceted marker in chronic kidney disease5
Tracing all patients who received insured dialysis treatment in Japan and the present situation of their number of deaths5
Factors predicting the recovery from acute kidney injury in children with primary nephrotic syndrome5
Constipation and diabetic kidney disease: The Fukuoka Diabetes Registry5
Ultrasonographic reference values and a simple yet practical formula for estimating average kidney length in Japanese children5
Prognostic impact of renal sinus fat accumulation in patients with chronic kidney disease5
Sex differences in clinical outcomes in Japanese incident dialysis patients: a prospective observational multicenter study5
Clinical parameters among patients in Japan with anemia and non-dialysis-dependent chronic kidney disease with and without diabetes mellitus who received roxadustat5
Factors associated with 1-year changes in serum fibroblast growth factor 23 levels in pediatric patients with chronic kidney disease5
Profiling of kidney involvement in systemic lupus erythematosus by deep learning using the National Database of Designated Incurable Diseases of Japan5
Predictive factors and management of urinary tract infections after kidney transplantation: a retrospective cohort study5
Acute kidney injury in cancer patients5
Factors associated with anti-SARS-CoV-2 spike antibody titers after a second BNT162b2 mRNA COVID-19 vaccination in Japanese hemodialysis patients5
Immune checkpoint inhibitor-associated acute kidney injury in patients with cancer: a systematic review and meta-analysis of risk factors5
Effects of phospholipase A2 receptor and thrombospondin type-1 domain-containing 7A expression in glomerular basement membranes on treatment response and renal outcome in membranous nephropathy5
Risk factors for the in-hospital mortality of CRRT-therapy patients with cardiac surgery-associated AKI: a single-center clinical study in China4
N-terminal pro brain natriuretic peptide predicts both all-cause and cardiovascular disease mortality in Japanese hemodialysis patients4
Cyclosporine A C1.5 monitoring reflects the area under the curve in children with nephrotic syndrome: a single-center experience4
The immunohistochemical expression of von Willebrand factor, T-cadherin, and Caveolin-1 is increased in kidney allograft biopsies with antibody-mediated injury4
The effect of renal replacement therapy on health-related quality of life in end-stage renal disease: a meta-analysis4
Weight loss reduces the incidence of dipstick proteinuria: a cohort study from the Japanese general population4
The effect of a single dose of BNT162b2 vaccine on the incidence of severe COVID-19 infection in patients on chronic hemodialysis: a single-centre study4
Neuroimmune system-mediated renal protection mechanisms4
Hepatocyte growth factor ameliorates methylglyoxal-induced peritoneal inflammation and fibrosis in mouse model4
Lateral spine dual-energy X-ray absorptiometry and the risk of fragility fractures in long-term kidney graft recipients4
Efficacy and limitations of additional steroid pulse therapy in IgA nephropathy patients whose hematuria did not remit on tonsillectomy and protocol steroid pulse therapy4
Safety and effectiveness of ferric citrate hydrate in serum phosphorus management of patients with chronic kidney disease: a long-term, real-world, observational, post-marketing surveillance study4
Prevalence, treatment status, and predictors of anemia and erythropoietin hyporesponsiveness in Japanese patients with non-dialysis-dependent chronic kidney disease: a cross-sectional study4
Post-kidney transplant soluble Klotho levels are determined by pretransplant soluble Klotho levels in both living donors and recipients4
Association of the nutritional risk index for Japanese hemodialysis with mortality and dietary nutritional intake in patients undergoing hemodialysis during long-term hospitalization4
Correlation between IgAC3 ratio and oxford score in IgA nephropathy4
Prognostic factors of IgA nephropathy presenting with mild proteinuria at the time of diagnosis (a multicenter cohort study)4
Predictive value of suPAR in AKI: a systematic review and meta-analysis4
Clinical features of autosomal recessive polycystic kidney disease in the Japanese population and analysis of splicing in PKHD1 gene for determination of phenotypes4
Epidemiology and temporal changes in the prognosis of rapidly progressive glomerulonephritis in Japan: a nationwide 1989–2015 survey4
Demographic, clinical and laboratory characteristics of rapidly progressive glomerulonephritis in Turkey: Turkish Society of Nephrology-Glomerular Diseases (TSN-GOLD) Working Group4
Selectivity of HIF-PH inhibitors: concerns regarding possible off-target effects4
Pathophysiology of encapsulating peritoneal sclerosis: lessons from findings of the past three decades in Japan4
Long-term social outcome after pediatric kidney transplantation: a single-center experience4
Predictive factors of long-term disease remission after rituximab administration in patients with childhood-onset complicated steroid-dependent nephrotic syndrome: a single-center retrospective study4
Clinical and histopathological features of acute kidney injury in adult-onset minimal change nephrotic syndrome4
Serum alkaline phosphatase and infection-related mortality in hemodialysis patients: ten-year outcomes of the Q-cohort study4
Association between COVID-19 vaccination and relapse of glomerulonephritis4
Incidence and risk factors of overcorrection in patients presenting with severe hyponatremia to the emergency department4
Peritoneal dialysis (PD) technique training: what features influence learning time?4
Activation of necroptosis pathway in podocyte contributes to the pathogenesis of focal segmental glomerular sclerosis4
Prevalence of latent tuberculosis infection and its risk factors in Japanese hemodialysis patients4
Prevalence and determinants of chronic kidney disease in urban adults’ populations of northern Cameroon4
Association of polypharmacy with incidence of CKD: a retrospective cohort study4
Decreased GM3 correlates with proteinuria in minimal change nephrotic syndrome and focal segmental glomerulosclerosis4
Peritoneal dialysis training performed remotely: results and comparison with Home Training4
Neferine mitigates cisplatin-induced acute kidney injury in mice by regulating autophagy and apoptosis4
Prevalence, clinical course and outcomes of COVID-19 in peritoneal dialysis (PD) patients: a single-center experience4
Role of IGF-1R in epithelial–mesenchymal transdifferentiation of human peritoneal mesothelial cells3
Etiology and outcomes of acute kidney disease in children: a cohort study3
Physical activity in patients with pre‑dialysis chronic kidney disease is associated with decreased renal function3
Renal protective effects of astragalus root in rat models of chronic kidney disease3
Do you recommend tonsillectomy for elderly patients with IgA nephropathy?3
Humoral and cellular response after BNT162b2 vaccine booster in hemodialysis patients and kidney transplant recipients3
Urinary cell cycle biomarkers for the prediction of renal non-recovery in patients with septic acute kidney injury: a prospective study3
Comparison of survival rates between incident hemodialysis patients and peritoneal dialysis patients: a 5-year prospective cohort study with propensity score matching3
Monthly trends and seasonality of hemodialysis treatment and outcomes of newly initiated patients from the national database (NDB) of Japan3
All reported non-canonical splice site variants in GLA cause aberrant splicing3
Canagliflozin protects the cardiovascular system through effects on the gut environment in non-diabetic nephrectomized rats3
Clinical and histological features in pediatric and adolescent/young adult patients with renal disease: a cross-sectional analysis of the Japan Renal Biopsy Registry (J-RBR)3
Reference values for urinary protein, albumin, beta 2-microglobulin, and the alpha 1-microglobulin-to-creatinine ratio in Japanese children3
MiR-34a induces myofibroblast differentiation from renal fibroblasts3
Persistent hyperparathyroidism after preemptive kidney transplantation3
Effect on residual kidney function of shared decision-making in selection of dialysis therapy3
Parameters affecting prognosis after hemodialysis withdrawal: experience from a single center3
Effect of tolvaptan on renal involvement in patients with autosomal dominant polycystic kidney disease according to different gene mutations3
The clinical usage of liposomal amphotericin B in patients receiving renal replacement therapy in Japan: a nationwide observational study3
Prognostic factors for acute ischemic stroke in patients undergoing hemodialysis3
Point-of-care renal ultrasound: the SECONDS checklist3
Association of autosomal dominant polycystic kidney disease with cardiovascular disease: a US-National Inpatient Perspective3
Prognostic implication of lactic dehydrogenase-to-albumin ratio in critically ill patients with acute kidney injury3
Association between annual variability of potassium levels and prognosis in patients undergoing hemodialysis3
Public support for patients with intractable diseases in Japan: impact on clinical indicators from nationwide registries in patients with autosomal dominant polycystic kidney disease3
Segmental membranous nephropathy3
Fractalkine deficiency attenuates LPS-induced acute kidney injury and podocyte apoptosis by targeting the PI3K/Akt signal pathway3
Blockade of Indoleamine 2,3-Dioxygenase attenuates lipopolysaccharide-induced kidney injury by inhibiting TLR4/NF-κB signaling3
Involvement of necroptosis in contrast-induced nephropathy in a rat CKD model3
Living well with kidney disease by patient and care-partner empowerment: kidney health for everyone everywhere3
Early cardiovascular events and cardiovascular death after renal transplantation: role of pretransplant risk factors3
Clinicopathological significance of light chain deposition in IgA nephropathy3
High mortality and residual kidney damage with Coronavirus disease-19-associated acute kidney injury in northern India3
Utility of remission criteria for the renal prognosis of IgA nephropathy3
Treatment strategy with multidrug therapy and tonsillectomy pulse therapy for childhood-onset severe IgA nephropathy3
Elevation of creatine kinase is associated with acute kidney injury in hospitalized patients infected with seasonal influenza virus3
Association between prevalence of laxative use and history of bone fractures and cardiovascular diseases in patients with chronic kidney disease: the Fukuoka Kidney disease Registry (FKR) study3
Japanese clinical practice patterns of primary nephrotic syndrome 2021: a web-based questionnaire survey of certified nephrologists3
Impact of cisplatin-induced acute kidney injury on long-term renal function in patients with solid tumors3
A randomized double-blinded placebo-controlled clinical trial on protective effects of pentoxifylline on gentamicin nephrotoxicity in infectious patients3
Prefecture-specific prevalence of overweight/obesity is associated with regional variation in the incidence of treated ESKD in Japan3
Prognostic significance of albumin to alkaline phosphatase ratio in critically ill patients with acute kidney injury3
A digest of the evidence-based Clinical Practice Guideline for Rapidly Progressive Glomerulonephritis 20203
Valganciclovir prophylaxis for cytomegalovirus infection in pediatric kidney transplant recipients: a single-center experience3
Association of serum magnesium levels with renal prognosis in patients with chronic kidney disease2
NT-pro BNP level at dialysis initiation is a useful biomarker for predicting hospitalization for ischemic heart disease2
Deep learning analysis of clinical course of primary nephrotic syndrome: Japan Nephrotic Syndrome Cohort Study (JNSCS)2
A nationwide survey of MYH9-related disease in Japan2
Nationwide questionnaire survey on the management of chronic kidney disease for general practitioners in Japan2
Distribution of serum adiponectin isoforms in pediatric patients with steroid-sensitive nephrotic syndrome2
Association between 1-year changes in urinary albumin-to-creatinine ratio and kidney disease progression in Japanese individuals with diabetes: a historical cohort study2
A nationwide cross-sectional analysis of biopsy-proven Fabry nephropathy: the Japan Renal Biopsy Registry2
Butyrylcholinesterase level as an independent prognostic factor for overall survival in patients on maintenance hemodialysis: a single-center retrospective study2
Clinicopathological discordance in biopsy-proven nephrosclerosis: a nationwide cross-sectional study of the Japan Renal Biopsy Registry (J-RBR)2
Evaluation of ultrastructural alterations of glomerular basement membrane and podocytes in glomeruli by low-vacuum scanning electron microscopy2
d-Serine as a sensor and effector of the kidney2
Hydroxychloroquine suppresses anti-GBM nephritis via inhibition of JNK/p38 MAPK signaling2
Efficacy of dotinurad in patients with severe renal dysfunction2
Prognostic impact of urine cyclic AMP levels in patients with chronic kidney disease2
Genetic nephrotic syndrome associated with disturbed function of glomerular slit membrane and podocyte cytoskeleton in children2
The role of a novel mineralocorticoid receptor antagonist, finerenone, in chronic kidney disease: mechanisms and clinical advances2
Impact of inpatient educational programs on mortality after the start of dialysis therapy2
A mixed-method feasibility study of a novel transitional regime of incremental haemodialysis: study design and protocol2
Use of mycophenolate mofetil in patients with pediatric and adult primary nephrotic syndrome: information from a Japanese hospital claims database2
InsKid—a new mobile application (app) that measures the infundibulopelvic angle before retrograde intrarenal surgery more reliably than does other approaches: pilot study2
Relationship between compliance with management target values and renal prognosis in multidisciplinary care for outpatients with chronic kidney disease2
Clinical characteristics of patients with early relapse during B-cell depletion after rituximab treatment for complicated steroid-dependent nephrotic syndrome2
Target phosphate and calcium levels in patients undergoing hemodialysis: a post-hoc analysis of the LANDMARK study2
Design and methods of an open-label, randomized controlled trial to evaluate the effect of pemafibrate on proteinuria in CKD patients (PROFIT-CKD)2
Current antihypertensive treatment and treatment-resistant hypertension in Japanese patients with chronic kidney disease2
Association between hyporesponsiveness to erythropoiesis-stimulating agents and risk of brain hemorrhage in patients undergoing hemodialysis: the Q-Cohort Study2
Effectiveness of neutralizing antibody cocktail in hemodialysis patients: a case series of 20 patients treated with or without REGN-COV22
Natural-derived compounds and their mechanisms in potential autosomal dominant polycystic kidney disease (ADPKD) treatment2
A chalcone derivative retards renal cyst enlargement by inhibiting fluid secretion and cell proliferation in an in vitro model of polycystic kidney disease2
Outcome of advanced renal cell carcinoma arising in end-stage renal disease: comparison with sporadic renal cell carcinoma2
The implication of calf circumference and grip strength in osteoporosis and bone mineral density among hemodialysis patients2
Effects of sodium-glucose co-transporter 2 inhibitors on ultrafiltration in patients with peritoneal dialysis: a protocol for a randomized, double-blind, placebo-controlled, crossover trial (EMPOWERED2
Cytosolic mtDNA–cGAS–STING axis contributes to sepsis-induced acute kidney injury via activating the NLRP3 inflammasome2
Evaluation of appropriate treatment for IgA nephropathy with mild proteinuria and normal renal function2
Overlapping obesity-related glomerulopathy and immunoglobulin A nephropathy: clinical and pathologic characteristics and prognosis2
Validation of the estimated glomerular filtration rate equation for Japanese children younger than 2 years2
0.03897500038147